Glenview Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Glenview Trust CO

$5.06 Billion
Q1 2025

A detailed history of Glenview Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Glenview Trust CO holds 3,515 shares of REGN stock, worth $1.96 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,515

Previous 3,071 14.46%

Holding current value

$1.96 Million

Previous $1.95 Million 14.48%

% of portfolio

0.04%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 20, 2025	BUY	$634.14 - $744.83 $281,558 - $330,704	444 Added 14.46%	3,515 $2.23 Million
Q4 2024 Feb 10, 2025	BUY	$701.85 - $1046.91 $17,546 - $26,172	25 Added 0.82%	3,071 $2.19 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $2,649 - $3,213	-3 Reduced 0.1%	3,046 $3.2 Million
Q4 2023 Feb 12, 2024	SELL	$775.18 - $881.7 $29,456 - $33,504	-38 Reduced 1.23%	3,049 $2.68 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $20,081 - $24,486	29 Added 0.95%	3,087 $2.54 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $21,700 - $25,740	-31 Reduced 1.0%	3,058 $2.2 Million
Q4 2022 Feb 08, 2023	BUY	$705.89 - $766.39 $144,707 - $157,109	205 Added 7.11%	3,089 $2.23 Million
Q3 2022 Nov 04, 2022	BUY	$573.97 - $724.32 $191,132 - $241,198	333 Added 13.05%	2,884 $1.99 Million
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $12,612 - $16,993	23 Added 0.91%	2,551 $1.51 Million
Q1 2022 May 11, 2022	SELL	$595.12 - $698.43 $595 - $698	-1 Reduced 0.04%	2,528 $1.77 Million
Q4 2021 Feb 10, 2022	SELL	$543.48 - $670.97 $57,065 - $70,451	-105 Reduced 3.99%	2,529 $1.6 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $14,350 - $17,024	25 Added 0.96%	2,634 $1.59 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $70,920 - $83,781	150 Added 6.1%	2,609 $1.46 Million
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $10,721 - $13,156	-24 Reduced 0.97%	2,459 $1.16 Million
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $5,739 - $7,295	-12 Reduced 0.48%	2,483 $1.2 Million
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $422,181 - $510,112	-775 Reduced 23.7%	2,495 $1.4 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $4,933 - $6,439	10 Added 0.31%	3,270 $2.04 Million
Q1 2020 Apr 28, 2020	BUY	$336.18 - $494.43 $15,128 - $22,249	45 Added 1.4%	3,260 $1.59 Million
Q4 2019 Feb 06, 2020	BUY	$274.13 - $376.51 $224,786 - $308,738	820 Added 34.24%	3,215 $1.21 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $318,580 - $370,924	1,165 Added 94.72%	2,395 $664,000
Q2 2019 Aug 08, 2019	BUY	$299.6 - $414.82 $368,508 - $510,228	1,230 New	1,230 $0

Others Institutions Holding REGN

# of Institutions

1,443

Shares Held

84.8M

Call Options Held

1.4M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $59.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Trust CO with notifications on news.

Account

Glenview Trust CO Regeneron Pharmaceuticals, Inc. Transaction History